Skip to main content

Usana Health Sciences Value Stock - Dividend - Research Selection

Usana health sciences

ISIN: US90328M1071 , WKN: 923145

Market price date:
Market price:  


Fundamental data and company key figures of the share

Annual reports in
Key figures
Cash flow
Net operating cash flow
Capital Expenditures
Free cash flow
Balance sheet
Total Equity
Liabilities & Shareholders equity
Income statement
Net income
Eps (diluted)
Diluted shares outstanding
Net sales/revenue

Fundamental ratios calculated on:

Ratios
Key figures
Cash flow
P/C
 
P/FC
Balance sheet
ROI
ROE
Income statement
P/E
Div. Yield%
P/B
P/S


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
Symbol
Market Capitalization USD
Country
Indices
Sectors
Raw Data Source
Stock Split
Internet


Description of the company

General

 

USANA Health Sciences, Inc., a Utah corporation, was founded in 1992 by Myron W. Wentz, Ph.D. We develop and manufacture high-quality, science-based nutritional and personal care products with a primary focus on promoting long-term health and reducing the risk of chronic degenerative disease. In so doing, we are committed to continuous product innovation and sound scientific research. We have operations in 19 markets worldwide, where we distribute and sell our products by way of direct selling. We have chosen this distribution method as we believe it is the most conducive to meeting our vision as a company, which is improving the overall health and nutrition of individuals and families around the world. Our net sales in fiscal year 2014 were $790.5 million, of which 81.8% were in markets outside of the United States. As a U.S.-based multi-national company with an expanding international presence, our operating results are sensitive to currency fluctuations, as well as economic and political conditions in markets throughout the world. Additionally, we are subject to the various laws and regulations in the United States, China, and the other markets in which we operate with respect to the products that we sell and to our method of distribution.

 

Our customer base comprises two types of customers: "Associates" and "Preferred Customers." Associates share in our company vision by acting as independent distributors of our products in addition to purchasing our products for their personal use. Preferred Customers purchase our products strictly for personal use and are not permitted to resell or to distribute the products. As of January 3, 2015, we had 349,000 active Associates and 81,000 active Preferred Customers worldwide.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov,


NEWS


Some Investors May Be Worried About USANA Health Sciences' (NYSE:USNA) Returns On Capital

2024-03-25
If you're looking for a multi-bagger, there's a few things to keep an eye out for. Ideally, a business will show two...

FSTA: Consumer Staples Sector Dashboard For March

2024-03-15

Usana Health Sciences Inc (USNA) Executive Chairman of the Board Kevin Guest Sells 11,011 Shares

2024-03-11
On March 11, 2024, Kevin Guest, the Executive Chairman of the Board of Usana Health Sciences Inc (NYSE:USNA), sold 11,011 shares of the company.

Usana Health Sciences Inc (USNA) Chief Scientific Officer Robert Sinnott Sells Company Shares

2024-03-06
Robert Sinnott, the Chief Scientific Officer of Usana Health Sciences Inc (NYSE:USNA), has sold 3,945 shares of the company on March 5, 2024, according to a recent SEC filing.

Usana Health Sciences Inc's Chief Legal Officer Joshua Foukas Sells Company Shares

2024-03-04
Usana Health Sciences Inc (NYSE:USNA), a company specializing in the development and manufacture of science-based nutritional and personal care products, has reported an insider sale according to a recent SEC filing.

Kevin Guest Says Leap Forward on Leap Day

2024-02-28
Every four years, we're given with a unique gift—one extra day. Feb. 29, 2024 is Leap Day, a rare occasion that offers an additional 24 hours in the year.

Warning: USNA is at high risk of performing badly

2024-02-27
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

USANA Sustainability and DEI Executive Director Awarded in Utah

2024-02-22
USANA Health Sciences, Inc. applauds Donald Cherry, executive director of corporate sustainability and DEI, for being named a 40 Under 40 award winner by Utah Business magazine.

Usana price target lowered by $5 at DA Davidson, here's why

2024-02-22
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Option Care Health (OPCH) and USANA Health (USNA)

2024-02-22
Looking for stock market analysis and research with proves results? Zacks.com offers in-depth financial research with over 30years of proven results.